database
FDA Recognizes Portion of MSK Oncology Knowledge Base in Public Human Genetic Variant Database
MSK's OncoKB is the first collection of somatic variants that the FDA has accepted for test developers to use in premarket validation studies.
In particular, the diagnostics company expects the new resource to strengthen its offerings to pharmaceutical partners, a key customer group.
Illumina, PierianDx Expand Partnership on Cancer Panel Test Reporting
The deal builds on a non-exclusive partnership signed in January 2019 and PierianDx will now support three more Illumina cancer sequencing assays.
Sema4 Raises $121M in Series C Financing Round
BlackRock, the world's largest investment manager, led the round, joined by new investors Deerfield Management and Moore Strategic Ventures as well as existing investors.
Fry Laboratories Plans COVID-19 NGS Diagnostic Kit Offering
The infectious disease testing firm has developed a sequencing-based coronavirus assay, which it plans to commercialize through its sister firm BioID Genomics.Â